Protagenic Therapeutics, Inc. (PTIX)
0.38
-0.04
(-8.97%)
USD |
OTCM |
Nov 20, 16:00
Protagenic Therapeutics Research and Development Expense (TTM) : 0.3714M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3714M |
| June 30, 2026 | 0.5628M |
| March 31, 2026 | 0.847M |
| December 31, 2025 | 1.647M |
| September 30, 2025 | 2.396M |
| June 30, 2025 | 2.542M |
| March 31, 2025 | 3.362M |
| December 31, 2024 | 3.942M |
| September 30, 2024 | 4.050M |
| June 30, 2024 | 4.810M |
| March 31, 2024 | 4.433M |
| December 31, 2023 | 3.320M |
| September 30, 2023 | 2.566M |
| June 30, 2023 | 1.943M |
| March 31, 2023 | 1.267M |
| December 31, 2022 | 1.589M |
| September 30, 2022 | 1.478M |
| June 30, 2022 | 1.234M |
| March 31, 2022 | 1.214M |
| December 31, 2021 | 1.137M |
| September 30, 2021 | 1.032M |
| June 30, 2021 | 1.315M |
| March 31, 2021 | 1.226M |
| December 31, 2020 | 0.6998M |
| September 30, 2020 | 1.174M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.6652M |
| March 31, 2020 | 0.7385M |
| December 31, 2019 | 0.8079M |
| September 30, 2019 | 0.4857M |
| June 30, 2019 | 0.6176M |
| March 31, 2019 | 0.8262M |
| December 31, 2018 | 0.8812M |
| September 30, 2018 | 0.9952M |
| June 30, 2018 | 0.9827M |
| March 31, 2018 | 0.7691M |
| December 31, 2017 | 0.7175M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| June 30, 2015 | |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Oncolytics Biotech, Inc. | 13.18M |
| Sangamo Therapeutics, Inc. | 113.79M |
| Sarepta Therapeutics, Inc. | 647.26M |
| Anixa Biosciences, Inc. | 4.828M |
| Vicapsys Life Sciences, Inc. | 0.0043M |